MDNA Life Sciences

MDNA Life Sciences is a biotechnology company developing proprietary diagnostic tests based on mitochondrial DNA biomarkers.

Its technology detects specific mitochondrial DNA deletions in blood and tissue samples as indicators of disease, enabling non-invasive testing for conditions that are difficult to diagnose.

Current products address high-grade prostate cancer and endometriosis, with a pipeline spanning ovarian, lung, liver, pancreatic, and stomach cancers.

The company operates a UKAS-accredited laboratory at Newcastle Helix.